Gynoxin (Fenticonazole Nitrate)

Gynoxin is indicated for the treatment of common vaginal fungal infections caused by Candida species. It is applied directly to the vaginal canal to relieve symptoms and eradicate the underlying yeast overgrowth.

• Vulvovaginal candidiasis (yeast infection) confirmed by clinical assessment.
• Acute vaginal yeast infection with itching, burning, or discharge.
• Recurrent Candida vaginitis when standard therapy has failed.
• Prophylactic treatment after antibiotic use to prevent yeast overgrowth.
• Adjunct therapy for mixed bacterial‑fungal vaginal infections.

The safety profile of Gynoxin reflects the typical adverse reactions observed with imidazole antifungals applied vaginally.

Common

• Mild vaginal irritation or burning sensation after application.
• Local itching or redness of the vulvar area.
• Unpleasant discharge or odor that resolves within days.
• Slight spotting or brownish discharge during the first days of treatment.
• Temporary increase in vaginal itching before symptoms improve.

Serious

• Severe allergic reaction such as swelling of the face or throat.
• Persistent or worsening vaginal pain and ulceration.
• Development of a new vaginal infection not responding to therapy.
• Signs of systemic toxicity like fever, chills, or rash.
• Signs of liver dysfunction such as jaundice or dark urine (rare).

When using Gynoxin, patients should follow specific precautions to minimize risks and ensure effective therapy.

• Avoid using the product if you have a known hypersensitivity to fenticonazole or other imidazoles.
• Do not insert the applicator beyond the recommended depth to prevent mucosal injury.
• Refrain from sexual intercourse or tampon use for at least 24 hours after application.
• Inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
• Keep the medication out of reach of children and store it at room temperature away from moisture.
• Discontinue use and seek medical advice if symptoms persist beyond the recommended treatment period.

Gynoxin may interact with other medicines or substances applied vaginally; consider the following guidance.

Avoid

• Concurrent use of other topical antifungal agents, which can increase local irritation.
• Insertion of spermicidal products or vaginal douches during treatment, as they may reduce drug efficacy.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) because of potential additive inhibition of fungal enzymes.
• Hormonal contraceptives administered vaginally, which could alter absorption of either product.
• Antibiotics taken orally that predispose to yeast overgrowth, requiring close monitoring of symptoms.
• Topical estrogen creams, because hormonal changes can affect vaginal flora and drug performance.